InsiderSignal.AI

InsiderSignal.ai

NEO - Neogenomics Inc

Insider Purchase by Zook Anthony P. (CEO)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

6 months ago, Zook Anthony P., serving as CEO at Neogenomics Inc (NEO), purchased 17,900 shares at $5.58 per share, for a total transaction value of $99,954.00. Following this transaction, Zook Anthony P. now holds 56,966 shares of NEO.

This purchase represents a 46.00% increase in Zook Anthony P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 6, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, August 6, 2025, meaning the disclosure happened on the same day as the trade.

Neogenomics Inc operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Zook Anthony P.

CEO

Anthony P. Zook, known as Tony Zook, is the Chief Executive Officer and Director of NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, a position he assumed in April 2025 after serving on the Board of Directors since 2023, where he chaired the Compensation Committee and served on the Audit and Technology Committees.[[1]](https://www.marketscreener.com/insider/ANTHONY-ZOOK-A0A9UJ/)[[2]](https://ir.neogenomics.com/news-events/press-releases/detail/292/tony-zook-assumes-role-as-chief-executive-officer-of-neogenomics)[[3]](https://ir.neogenomics.com/corporate-governance/board-of-directors)[[4]](https://ir.neogenomics.com/company-information/executive-team)[[5]](https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/management) With over three decades of experience in diagnostics and biopharma, Zook brings expertise in commercial operations, brand management, and bridging research and development with commercialization.[[2]](https://ir.neogenomics.com/news-events/press-releases/detail/292/tony-zook-assumes-role-as-chief-executive-officer-of-neogenomics)[[3]](https://ir.neogenomics.com/corporate-governance/board-of-directors) Zook's career highlights include serving as Executive Vice President of Global Commercial Operations at AstraZeneca PLC from 2010 to 2013, overseeing global P&L for all brands and commercializing 10 brands exceeding $1 billion in sales each, while leading MedImmune's global biologics business and chairing the Commercial Investment Board.[[1]](https://www.marketscreener.com/insider/ANTHONY-ZOOK-A0A9UJ/)[[3]](https://ir.neogenomics.com/corporate-governance/board-of-directors)[[4]](https://ir.neogenomics.com/company-information/executive-team) Previously, he was CEO of Innocoll Holdings Plc (2017-2019) and Innocoll Biotherapeutics (2014-2015), Vivus, Inc. (until 2013), and spent 14 years at Berlex Laboratories in various roles.[[1]](https://www.marketscreener.com/insider/ANTHONY-ZOOK-A0A9UJ/)[[3]](https://ir.neogenomics.com/corporate-governance/board-of-directors) He currently holds positions as Chairman of Algorithm Sciences, Inc. and Voltron Therapeutics, Inc. (since 2021), Director at ViralClear Pharmaceuticals, Inc. (since 2020), and others including Trustee at Healthcare Leadership Council.[[1]](https://www.marketscreener.com/insider/ANTHONY-ZOOK-A0A9UJ/) Zook is 64 years old with a net worth of approximately $285,572 as of mid-2025.[[1]](https://www.marketscreener.com/insider/ANTHONY-ZOOK-A0A9UJ/)[[5]](https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/management)

View full insider profile →

Trade Price

$5.58

Quantity

17,900

Total Value

$99,954.00

Shares Owned

56,966

Trade Date

Wednesday, August 6, 2025

200 days ago

SEC Filing Date

Wednesday, August 6, 2025

HEALTHCAREDIAGNOSTICS & RESEARCH

About Neogenomics Inc

Company Overview

No company information available
View news mentioning NEO

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/108833

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime